President Obama is pushing the term "Precision Medicine."
We have just completed our first ranking of biopharma companies based on how much they are driving innovation in personalized medicine, and Genentech scored the highest among 25 companies. Download the scorecard whitepaper:
- Metabolism biomarker testing dominates companion diagnostic (CDx) use
An article published in Nature last month describes a recent trend in which “oncologists are starting to prescribe expensive new drugs that target the genetic profiles of their patients’ tumors, even when those treatments have not been approved for the particular cancer involved.” Such "off-label" ...